|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/25/21 Kraig Biocraft Laboratories, Inc. S-1/A 63:12M M2 Compliance LLC/FA |
Document/Exhibit Description Pages Size
1: S-1/A Pre-Effective Amendment to Registration Statement HTML 2.97M
(General Form)
2: EX-23.1 Consent of Expert or Counsel HTML 19K
9: R1 Cover HTML 46K
10: R2 Condensed Consolidated Balance Sheets HTML 127K
11: R3 Condensed Consolidated Balance Sheets HTML 48K
(Parenthetical)
12: R4 Condensed Consolidated Statements of Operations HTML 85K
(Unaudited)
13: R5 Condensed Consolidated Statement of Changes in HTML 100K
Stockholders Deficit (Unaudited)
14: R6 Condensed Consolidated Statement of Changes in HTML 26K
Stockholders Deficit (Unaudited) (Parenthetical)
15: R7 Condensed Consolidated Statements of Cash Flows HTML 119K
(Unaudited)
16: R8 Summary of Significant Accounting Policies and HTML 176K
Organization
17: R9 Going Concern HTML 26K
18: R10 Equipment HTML 48K
19: R11 Right to Use Assets and Lease Liabilitity HTML 75K
20: R12 Accrued Interest - Related Party HTML 44K
21: R13 Note Payable HTML 41K
22: R14 Convertible Notes HTML 106K
23: R15 Stockholders? Deficit HTML 480K
24: R16 Commitments and Contingencies HTML 145K
25: R17 Related Party Transactions HTML 122K
26: R18 Subsequent Events HTML 41K
27: R19 Summary of Significant Accounting Policies and HTML 215K
Organization (Policies)
28: R20 Summary of Significant Accounting Policies and HTML 95K
Organization (Tables)
29: R21 Equipment (Tables) HTML 42K
30: R22 Right to Use Assets and Lease Liabilitity (Tables) HTML 51K
31: R23 Convertible Notes (Tables) HTML 72K
32: R24 Stockholders? Deficit (Tables) HTML 371K
33: R25 Schedule of Antidilutive Securities of Earnings HTML 32K
Per Share (Details)
34: R26 Schedule of Antidilutive Securities of Earnings HTML 27K
Per Share (Details) (Parenthetical)
35: R27 Schedule of Fair Value of Financial Instruments HTML 28K
(Details)
36: R28 Summary of Significant Accounting Policies and HTML 39K
Organization (Details Narrative)
37: R29 Going Concern (Details Narrative) HTML 28K
38: R30 Schedule of Property and Equipment (Details) HTML 36K
39: R31 Equipment (Details Narrative) HTML 21K
40: R32 Schedule of Right Use of Assets (Details) HTML 28K
41: R33 Schedule of Lease Liability (Details) HTML 37K
42: R34 Schedule of Lease Cost (Details) HTML 27K
43: R35 Right to Use Assets and Lease Liabilitity (Details HTML 64K
Narrative)
44: R36 Accrued Interest - Related Party (Details HTML 48K
Narrative)
45: R37 Note Payable (Details Narrative) HTML 56K
46: R38 Schedule of Fair Value Warrants (Details) HTML 45K
47: R39 Summary of Convertible Debt (Details) HTML 49K
48: R40 Convertible Notes (Details Narrative) HTML 85K
49: R41 Schedule of Option Assumption (Details) HTML 106K
50: R42 Schedule of Warrants Activity (Details) HTML 46K
51: R43 Schedule of Warrants Outstanding (Details) HTML 70K
52: R44 Schedule of Options Outstanding (Details) HTML 27K
53: R45 Stockholders? Deficit (Details Narrative) HTML 408K
54: R46 Commitments and Contingencies (Details Narrative) HTML 525K
55: R47 Related Party Transactions (Details Narrative) HTML 401K
56: R48 Subsequent Events (Details Narrative) HTML 74K
57: R49 Schedule of Deferred Tax Assets and Liabilities HTML 20K
(Details) (Parenthetical)
58: R50 Schedule of Deferred Tax Assets and Liabilities HTML 30K
(Details)
59: R51 Schedule of Components Deferred Income Taxes HTML 27K
(Details)
61: XML IDEA XML File -- Filing Summary XML 113K
8: XML XBRL Instance -- forms-1a_htm XML 3.40M
60: EXCEL IDEA Workbook of Financial Reports XLSX 107K
4: EX-101.CAL XBRL Calculations -- kblb-20210630_cal XML 134K
5: EX-101.DEF XBRL Definitions -- kblb-20210630_def XML 717K
6: EX-101.LAB XBRL Labels -- kblb-20210630_lab XML 1.21M
7: EX-101.PRE XBRL Presentations -- kblb-20210630_pre XML 926K
3: EX-101.SCH XBRL Schema -- kblb-20210630 XSD 192K
62: JSON XBRL Instance as JSON Data -- MetaLinks 352± 473K
63: ZIP XBRL Zipped Folder -- 0001493152-21-021233-xbrl Zip 427K
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the inclusion in this Registration Statement on Form S-1 of our report dated March 12, 2021, of Kraig Biocraft Laboratories, Inc. relating to the audit of the consolidated financial statements for the periods ending December 31, 2020 and 2019 and the reference to our firm under the caption “Experts” in the Registration Statement.
| /s/ M&K CPAS, PLLC | |
| www.mkacpas.com | |
| Houston, Texas | |
| August 25, 2021 |
C:
| This ‘S-1/A’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 8/25/21 | |||
| 3/12/21 | 10-K | |||
| 12/31/20 | 10-K, 5 | |||
| 12/31/19 | 10-K | |||
| List all Filings | ||||